Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
693 SQZ-AAC-HPV-101: initial data from a phase I dose escalation/expansion study of SQZ-AAC-HPV, a red blood cell-based therapeutic cancer vaccine for HPV16+ solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
